About Teresa Whalen
Form D filings for CytoAgents from 2021 to 2023 list Teresa Whalen as chief executive officer and president, director.
Teresa Whalen first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Teresa Whalen in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Teresa Whalen works with at each company, as listed on that company's latest Form D.
CytoAgents, Inc. · Form D, May 16, 2023
RP
Roy Prieb
Chief Financial Officer
RF
Robert Ferris
Director
SM
Stanley Marks
Director
AM
Anthony McCarley
Director
CM
Catherine Mott
Director